CN117647571A - Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof - Google Patents
Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof Download PDFInfo
- Publication number
- CN117647571A CN117647571A CN202311375842.0A CN202311375842A CN117647571A CN 117647571 A CN117647571 A CN 117647571A CN 202311375842 A CN202311375842 A CN 202311375842A CN 117647571 A CN117647571 A CN 117647571A
- Authority
- CN
- China
- Prior art keywords
- electrode
- forming
- working electrode
- layer
- electrochemical biosensor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 32
- 239000012491 analyte Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000011248 coating agent Substances 0.000 claims abstract description 45
- 238000000576 coating method Methods 0.000 claims abstract description 45
- 102000004190 Enzymes Human genes 0.000 claims abstract description 29
- 108090000790 Enzymes Proteins 0.000 claims abstract description 29
- 239000000758 substrate Substances 0.000 claims abstract description 24
- 238000001035 drying Methods 0.000 claims abstract description 18
- 230000027756 respiratory electron transport chain Effects 0.000 claims abstract description 17
- 239000003054 catalyst Substances 0.000 claims abstract description 13
- 229910021607 Silver chloride Inorganic materials 0.000 claims abstract description 9
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims abstract description 9
- 239000008055 phosphate buffer solution Substances 0.000 claims abstract description 6
- 239000007772 electrode material Substances 0.000 claims abstract description 5
- 239000002002 slurry Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 20
- -1 polydimethylsiloxane Polymers 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 17
- 229920001577 copolymer Polymers 0.000 claims description 11
- 229920000557 Nafion® Polymers 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 10
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- 229920002635 polyurethane Polymers 0.000 claims description 9
- 239000004814 polyurethane Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920000570 polyether Polymers 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229920002396 Polyurea Polymers 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 6
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 6
- 229910052762 osmium Inorganic materials 0.000 claims description 5
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 4
- 229920001661 Chitosan Polymers 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 229910017052 cobalt Inorganic materials 0.000 claims description 4
- 239000010941 cobalt Substances 0.000 claims description 4
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 4
- 150000002484 inorganic compounds Chemical class 0.000 claims description 4
- 229910010272 inorganic material Inorganic materials 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 4
- 239000004800 polyvinyl chloride Substances 0.000 claims description 4
- 229920002717 polyvinylpyridine Polymers 0.000 claims description 4
- 238000007650 screen-printing Methods 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000004544 sputter deposition Methods 0.000 claims description 4
- 239000004642 Polyimide Substances 0.000 claims description 3
- 239000006087 Silane Coupling Agent Substances 0.000 claims description 3
- 239000000560 biocompatible material Substances 0.000 claims description 3
- 239000003575 carbonaceous material Substances 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 229920001721 polyimide Polymers 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims description 3
- 125000005504 styryl group Chemical group 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 238000007772 electroless plating Methods 0.000 claims description 2
- 238000005566 electron beam evaporation Methods 0.000 claims description 2
- 238000009713 electroplating Methods 0.000 claims description 2
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 229910052741 iridium Inorganic materials 0.000 claims description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 238000000608 laser ablation Methods 0.000 claims description 2
- 238000000707 layer-by-layer assembly Methods 0.000 claims description 2
- 239000011133 lead Substances 0.000 claims description 2
- 239000007769 metal material Substances 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 239000002086 nanomaterial Substances 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 229960002317 succinimide Drugs 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 claims description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 2
- 238000001764 infiltration Methods 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 25
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 22
- 239000008103 glucose Substances 0.000 description 22
- 108010015776 Glucose oxidase Proteins 0.000 description 12
- 239000004366 Glucose oxidase Substances 0.000 description 12
- 229940116332 glucose oxidase Drugs 0.000 description 12
- 235000019420 glucose oxidase Nutrition 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000000970 chrono-amperometry Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000007598 dipping method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000002484 cyclic voltammetry Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000003373 anti-fouling effect Effects 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000002041 carbon nanotube Substances 0.000 description 2
- 229910021393 carbon nanotube Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 150000002303 glucose derivatives Chemical class 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 229920006264 polyurethane film Polymers 0.000 description 2
- 229960003351 prussian blue Drugs 0.000 description 2
- 239000013225 prussian blue Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002519 antifouling agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001903 differential pulse voltammetry Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000000157 electrochemical-induced impedance spectroscopy Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
The invention provides a preparation method of an electrochemical biosensor electrode suitable for analyte detection, which comprises the following steps: (1) forming an electrode layer on a substrate surface: forming electrode material on the surface of the substrate to form a patterned electrode system, conductive lines and contacts; (2) Coating Ag/AgCl slurry on the surface of the reference electrode, and drying to form an Ag/AgCl reference electrode; (3) Modifying an electron transfer mediator or a catalyst on the surface of the working electrode; (4) forming an enzyme layer on the surface of the working electrode; (5) Forming a mass transport limiting layer on the surface of the working electrode: (6) forming an anti-interference layer on the surface of the working electrode; (7) Forming a biocompatible coating on a sensor electrode end of the working electrode; (8) Immersing the whole modified electrode into 0.01M phosphate buffer solution with pH of 7.4 for 4-48h, so that each component and the coating are fully combined, the stability of the electrode is enhanced, and the prepared electrochemical biosensor electrode is obtained.
Description
Technical Field
The present invention relates to the field of analyte detection devices, and in particular, to the field of analyte detection devices. To an electrochemical biosensor electrode.
Background
Prior art disclosures or literature: CN110044986B, CN111803086B, etc.
The similar technical characteristics are as follows: the design of electrode layering modification has certain similarity, and part of selected materials have certain similarity.
Background introduction:
the blood and body fluid components are directly related to physiological health level, and the detection and analysis of different components are of great medical significance for judging physiological condition of human body. Electrochemical biosensors are widely used in the field of analyte detection because they can convert biochemical signals into electrical signals for acquisition and amplification. As in continuous blood glucose monitoring devices for diabetes management, minimally invasive continuous monitoring of glucose levels to aid in insulin therapy; or various electrochemical detection chips and devices for in vitro analyte detection. Chinese patent No. CN201811640898.3 discloses a working electrode for a glucose monitoring probe, which comprises: a base layer; a glucose sensing layer formed on the substrate layer and having a glucose enzyme capable of chemically reacting with glucose; a semipermeable membrane formed on the glucose sensing layer for controlling the passage rate of glucose molecules; and a biocompatible film formed on the semipermeable film, wherein a nanoparticle layer that catalyzes a glucose reaction and is porous is provided between the base layer and the glucose sensing layer, and the glucose permeates the nanoparticle layer. According to the present disclosure, the working electrode working voltage can be reduced, interference can be reduced, the service life of the glucose monitoring probe can be prolonged, and the sensitivity of the reaction to glucose can be improved. According to the three-electrode subcutaneous implanted glucose sensor and the manufacturing method thereof disclosed by the invention, the sensor adopts a three-electrode form of a working electrode, a reference electrode and an auxiliary electrode, and the micro-current to be tested passes through the working electrode and the auxiliary electrode, and the reference electrode basically does not pass through the current, so that the service life of the reference electrode is prolonged; the manufacturing process of the sensor electrode is improved, so that the process is simple, the quality is controllable, the stability of the glucose oxidase of the working electrode is maintained, and the accuracy of sensor test data is ensured; in addition, carriers such as bovine serum albumin are omitted, and the activity and stability of glucose oxidase are ensured by adopting a glutaraldehyde and silane dual-function coupling mode, so that the potential safety hazard to a human body is reduced, and the rejection reaction of the human body is lightened; through the detachable block connected mode of transmitter and sensor for sensor and transmitter can conveniently separate, and the transmitter can also used repeatedly after realizing changing the sensor, has reduced user's use cost.
In general, electrochemical biosensors are used in devices for continuous blood glucose monitoring, and a current signal is measured and acquired in real time by using a chronoamperometry method, and the physiological glucose level is reflected by the current signal level; in the in vitro analyte detection process, various detection means including cyclic voltammetry, differential pulse voltammetry, electrochemical impedance spectroscopy, chronoamperometry and the like can be used to collect signals and establish the correspondence between electrical signals and analytes.
Various types of continuous testing devices and in vitro analytical devices are now successfully commercialized and put into medical testing applications. Especially in the fields of diabetes management and in-vitro analyte detection, the method has wide audience and high popularization rate. However, due to numerous problems that exist in practice, such as:
1. the reference electrode is continuously worn, and the continuous measurement time is long, so that the misalignment is easy to cause.
2. The noble metal electrode microfilaments have higher cost and serious resource waste.
3. Bovine serum albumin is used as an electrode anti-fouling agent, and when an electrode probe is used for minimally invasive implantable detection, the rejection reaction of the organism is easily induced.
4. Glutaraldehyde is used as a cross-linking agent, and biological toxicity is easy to occur to human bodies when inactivation is incomplete or residues exist.
5. The working electrode and the counter electrode in the electrode probe are far away, a stable loop is not easy to form, the electrode probe is easy to be interfered, and the measuring current fluctuates.
6. Each modification substance on the surface of the electrode is not firmly fixed, and the risk of falling off exists.
These problems lead to unstable performance, hidden safety hazards and high price in the application process of the electrochemical biosensor, and are questioned by partial patients and users. Therefore, how to build an electrochemical biosensor detection platform with stable performance, safety, low process cost and sustainable use is a key problem at present, and the above problems are needed to be solved and optimized.
Disclosure of Invention
In order to overcome the deficiencies of the prior art, the present invention provides an electrochemical biosensor electrode suitable for analyte detection,
the technical scheme of the invention is as follows: a method of making an electrochemical biosensor electrode suitable for analyte detection comprising the steps of:
(1) Forming an electrode layer on the surface of a substrate: forming electrode materials on the surface of a substrate to form patterned electrodes, conductive circuits and contacts; the electrode system comprises at least one counter electrode, one working electrode and one reference electrode;
(2) And coating Ag/AgCl slurry on the surface of the reference electrode, and drying to form the Ag/AgCl reference electrode.
(3) The surface of the working electrode is modified with an electron transfer mediator/catalyst: prussian blue is electrodeposited by chronoamperometry/cyclic voltammetry on the working electrode surface to form an electron transfer mediator.
(4) Forming an enzyme layer on the surface of the working electrode: glucose oxidase is dissolved in phosphate buffer solution, and 1-ethyl- (3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide are added for treatment so as to activate carboxyl groups on the surface of the glucose oxidase.
(5) And dipping or coating or spraying an amino silane layer on the surface of the working electrode, and combining the activated glucose oxidase with the silane layer in a dipping or coating or spraying mode to complete the fixation of the enzyme layer.
(6) Forming a mass transport limiting layer on the surface of the working electrode: the polyethylene glycol-polyurethane blend liquid is coated on the surface of the working electrode to serve as a mass transportation limiting layer, and the polyethylene glycol-polyurethane film formed after drying can play a role in limiting the glucose transportation rate so as to achieve the purpose of ensuring sufficient oxygen in the enzyme layer.
(7) Forming an anti-interference layer on the surface of the working electrode: nafion solution is coated on the surface of the working electrode to be used as an anti-interference coating, and the coating is dried to form a film, so that foreign matters are prevented from being adsorbed on the surface of the electrode, and the working performance of the electrode is prevented from being rapidly reduced.
(8) Forming a biocompatible coating on the sensor electrode end: and (3) coating a polyvinylpyrrolidone solution on the surface of the working electrode as a biocompatible coating, drying the coating to form a film, and increasing the biocompatibility of the sensor electrode.
(9) And immersing the whole electrode end part modified by each component and the coating into 0.01M phosphate buffer solution with the pH of 7.4 for 4-48 hours, so that each component and the coating are fully combined, the stability of the electrode is enhanced, and the prepared electrochemical biosensor electrode is obtained.
The electrochemical biosensor electrode suitable for analyte detection is characterized in that an electrode layer is formed on the surface of a substrate, and an electron transfer mediator/catalyst is modified on the surface of a working electrode to play a role in enhancing electron transfer efficiency, reducing the working potential of the sensor and catalyzing and decomposing the analyte under low potential.
Further, an enzyme layer is formed on the surface of the working electrode, and the enzyme layer screens, identifies and orients the analyte to be detected in the system to generate oxidation-reduction reaction, and conducts electrons to the electrode through the medium of an electron transfer mediator/catalyst so as to realize conversion from biochemical signals to electric signals.
Further, a mass transport limiting layer is formed on the surface of the working electrode, and the oxygen content fluctuation in the detection system can cause the sensor electrode to acquire signals to be influenced, for example, when the oxygen content is too high/too low, the sensitivity, the linear range and the response speed of the sensor for detecting certain biochemical reactions can be influenced, so that the mass transport limiting layer is required to control the ratio of oxygen to analyte in the enzyme layer so as to enable the biochemical reactions to stably proceed.
Further, an anti-interference layer is formed on the surface of the working electrode, and the anti-interference layer is required to be formed on the surface of the sensor electrode in order to avoid the rapid reduction of the working performance of the sensor caused by the adsorption and encapsulation of foreign matters in a long-time use environment based on the analysis of the implantation of the electrode end of the sensor into the skin layer of a human body.
Further, based on possible analysis of some application scenes of the skin layer implanted in the human body, in order to reduce rejection reaction related to the human body and occurrence of discomfort, inflammation, allergy and other phenomena of surrounding skin tissues after the sensor is implanted, a biocompatible coating is formed at the end part of the sensor electrode so as to ensure the safety of application.
The potential analytes which can be detected by the prepared electrochemical biosensor can be various substances such as lactic acid, alcohol, ketone, glucose, bilirubin, urea, uric acid, cholesterol, acetylcholine, ascorbic acid, amino acid, sodium ion, potassium ion, calcium ion, chloride ion, oxygen, carbon dioxide, pH, antibiotics, glutamine and the like.
The substrate can be a flexible or rigid substrate, and the flexible substrate is selected from polyimide, polyester, polyether, polydimethylsiloxane, polyvinylpyrrolidone, polyolefin, polytetrafluoroethylene and the like and copolymers formed by the above substances, or a flexible glass sheet, a flexible metal sheet, an inorganic compound oxide film and the like; the rigid substrate is selected from silicon dioxide, metal oxide, hard plastic, ceramic, polymethyl methacrylate, various resins and the like.
The electrode system specifically comprises at least one counter electrode, one working electrode and one reference electrode, wherein the electrode system can be a single counter electrode corresponding to a single working electrode or a single counter electrode corresponding to a plurality of working electrode systems, and the reference electrode only plays a role in providing reference potential. The electrode positional relationship may be coplanar, off-plane, or off-plane. The electrode material can be carbon-based material, metal material, inorganic compound material, organic biochemical material, etc., and the specific process method for forming the electrode coating can be screen printing, spraying, coating, soaking and drying, sputtering, electron beam evaporation, etc.
The electron transfer mediator may be a complex based on a transition metal element such as osmium, ruthenium, iron, cobalt, vanadium, or the like, ferricyanide, ferrocenyl derivative, or the like.
The catalyst can be platinum, silver, gold, lead, nickel, cobalt, titanium, iridium, ruthenium and other metal nano materials. The process used to form the electron transfer mediator/catalyst may be electroplating, electroless plating, sputtering, immersion drying, laser ablation, and the like.
Furthermore, the enzyme layer material formed is different according to different selected enzymes for the specific analytes, and the important marker glucose for diabetes blood glucose management is taken as an example, and enzymes such as glucose oxidase, glucose dehydrogenase and the like can be selected to be modified on the surface of the working electrode. The enzyme layer is not necessarily composed of a single enzyme, but may be composed of a plurality of enzymes, for example, a combination of a specific enzyme and a peroxidase. The enzyme layer may be formed by physical adsorption, crosslinking, layer-by-layer assembly, etc., and the crosslinking agent may be glutaraldehyde, a silane coupling agent, a succinimide substance, a carbodiimide substance, etc.
The material of the mass transport limiting film can be polyether, polyurea, polyurethane, polyvinyl pyridine, polyvinyl imidazole, polyvinylpyrrolidone, styryl polymer, polyethylene glycol, polytetrafluoroethylene, polyvinyl chloride, polymethyl methacrylate, nafion polymer, chitosan, sodium alginate, agar and the like, and copolymers formed among the above substances. The process method for forming the mass transport limiting layer can be spraying, coating, soaking, drying and the like.
The further formed anti-interference layer material can be polyether, polyurea, polyurethane, polyvinyl pyridine, polyvinyl imidazole, polyvinylpyrrolidone, styryl polymer, polyethylene glycol, polytetrafluoroethylene, polyvinyl chloride, polymethyl methacrylate, nafion polymer and the like and copolymers formed among the above substances. The process method for forming the mass transport limiting layer can be spraying, coating, soaking, drying and the like.
The further formed biocompatible coating material can be polylactic acid, polyurethane, polyurea, polyether, polyolefin, polyethylene glycol, polyvinyl alcohol, polyvinylpyrrolidone, nafion polymer, chitosan, sodium alginate, agar substance and copolymer formed between the above substances.
The electron transfer mediator/catalyst and enzyme may be pre-attached and co-incubated on the surface of the working electrode.
The enzyme may be pretreated to allow the enzyme to unfold exposing the corresponding active site.
The enzyme and mass transport limiting material may be pre-mixed and co-incubated on the working electrode surface.
The mass transport limiting material, the anti-interference material and the biocompatible material in steps (5) (6) (7) may be pre-mixed and co-incubated on the same layer of the working electrode surface, or may be performed once, such that the mass transport limiting material, the anti-interference material and the biocompatible material are located on different layers of the working electrode surface.
The beneficial effects of the invention are as follows: the electrochemical biosensor has the advantages that the reference electrode area is larger, a sufficient action area and reserve quantity are provided for Ag/AgCl, the service life of the sensor electrode can be prolonged, the potential stability is enhanced, and the problem of sensor misalignment caused by rapid reference electrode loss due to chloride ion loss is avoided to a great extent.
According to the electrochemical biosensor, the carbon material and the polymer substrate are adopted as the electrode and the substrate, so that the production cost can be greatly reduced, and the waste of metal resources can be reduced.
The electrochemical biosensor adopts the anti-fouling layer formed by polyethylene glycol and polyurethane substances to block the foreign matter adsorption electrode, and the surface of the electrode treated by the silane coupling agent has a large number of hydrophilic groups to assist the anti-fouling coating to play a role together, so that the use of bovine serum albumin on the surface of the electrode is eliminated, and the rejection reaction possibly caused when the electrode is implanted into the skin layer of a human body is avoided.
The electrochemical biosensor adopts the interdigital electrode design, ensures the tight position relation between the working electrode and the counter electrode, forms a stable conductive loop in an electrolyte system, and can reduce signal fluctuation noise caused by instability of the electrode loop.
After the preparation and modification of each layer of the electrochemical biosensor electrode are finished, the electrochemical biosensor electrode is fully soaked in a wetting environment or a buffer solution environment, so that all layers are fully combined, and the connection is tight.
Description of the drawings:
FIG. 1 is a flow chart of a process for preparing an electrode for an electrochemical biosensor according to the present invention.
Fig. 2 is a schematic diagram of the patterned electrode, conductive line and contact prepared in step 1.
FIG. 3a is a schematic view of a coplanar single electrode
Fig. 3b is a schematic illustration of a coplanar multi-electrode.
Fig. 4a is a schematic front view of an out-of-plane electrode.
FIG. 4b is a schematic reverse side view of an electrode with different sides.
Fig. 5 is a schematic view of a dissimilar electrode.
FIG. 6 is a schematic diagram of the working electrode, counter electrode and reference electrode supported on three substrates, respectively
Detailed Description
In order to make the technical scheme and technical effects of the invention more clear, the invention is further described below with reference to specific embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
Example 1
As shown in fig. 1, a method for preparing an electrochemical biosensor electrode suitable for analyte detection, comprising the steps of:
(1) And (3) carrying out screen printing on the surface of the polyimide substrate with a carbon paste electrode, wherein the proportion of the carbon nano tubes in the carbon paste is 1% -20%, and drying to form the patterned carbon electrode, the conductive circuit and the contact after printing is completed. The explanation about the electrode, the conductive line, the contact, etc. is shown in fig. 2, wherein the two interdigital electrodes, namely, the electrode 1 and the electrode 2 are respectively a working electrode and a counter electrode; the square electrode, electrode 3, is the reference electrode. It should be noted that the preferred results are described in this embodiment, and the electrodes may be exchanged with each other, for example, electrode 1 may be a counter electrode or a reference electrode, electrode 2 may be a working electrode or a reference electrode, and electrode 3 may be a working electrode or a counter electrode. Each electrode is connected with one contact, and at least one conductive line is arranged between the electrode and the corresponding contact. The region formed by the whole of each electrode is a detection region, that is, a region that plays a role in detection in practical use. The region formed by the whole of each contact is a contact region, namely, a region electrically connected with external electric equipment in practical application. The working electrode may be one or more, and is shown in fig. 3a as a schematic diagram of a coplanar single electrode, and in fig. 3b as a schematic diagram of a coplanar multiple electrode, where at least one counter electrode and one reference electrode are respectively present in addition to the working electrode. As shown in fig. 4a and 4b, the electrode may be located on different sides, for example, the working electrode, the counter electrode and the reference electrode are located on opposite sides of the substrate. As shown in fig. 5, the electrode may be in a different type, and the working electrode, the counter electrode and the reference electrode are supported on three substrates, respectively.
(2) And (3) coating Ag/AgCl slurry on the surface of the reference electrode, and drying to form the Ag/AgCl reference electrode.
(3) Prussian blue is electrodeposited by chronoamperometry/cyclic voltammetry on the working electrode surface to form an electron transfer mediator.
(4) Glucose oxidase is dissolved in phosphate buffer solution, and 1-ethyl- (3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide are added for treatment so as to activate carboxyl groups on the surface of the glucose oxidase.
(5) And dipping or coating or spraying an amino silane layer on the surface of the working electrode, and combining the activated glucose oxidase with the silane layer in a dipping or coating or spraying mode to complete the fixation of the enzyme layer.
(6) The polyethylene glycol-polyurethane blend liquid is coated on the surface of the working electrode to serve as a mass transportation limiting layer, and the polyethylene glycol-polyurethane film formed after drying can play a role in limiting the glucose transportation rate so as to achieve the purpose of ensuring sufficient oxygen in the enzyme layer.
(7) Nafion solution is coated on the surface of the working electrode to be used as an anti-interference coating, and the coating is dried to form a film, so that foreign matters are prevented from being adsorbed on the surface of the electrode, and the working performance of the electrode is prevented from being rapidly reduced.
(8) And (3) coating a polyvinylpyrrolidone solution on the surface of the working electrode as a biocompatible coating, drying the coating to form a film, and increasing the biocompatibility of the sensor electrode.
(9) The electrode end after the modification of each component and coating is immersed in 0.01M phosphate buffer solution with pH of 7.4 for 4-48h to enable each component and coating to be fully combined, so that the stability of the electrode is enhanced, and the prepared electrochemical biosensor electrode is obtained, which is schematically shown in figure 6, wherein a substance 1 represents a substrate, a substance 2 represents an electron transfer mediator/catalyst, a substance 3 represents an enzyme layer, a substance 4 represents a mass transport limiting layer, a substance 5 represents an anti-interference layer, and a substance 6 represents a biocompatible coating.
The electrochemical biosensor electrode is matched with a hollow stainless steel microneedle to assist in puncturing skin, can be implanted into a skin layer, is further connected with electrical equipment through a contact, applies working voltage to a sensor, collects measurement data, performs post-treatment on the data, and can realize continuous glucose measurement of a human body.
Example 2
The difference from example 1 is that:
in the step (1), a carbon paste electrode is screen-printed on the surface of the polyethylene terephthalate substrate.
In the step (3), silver nano particles are deposited on the surface of the working electrode by a chronoamperometric method to serve as a catalyst.
In the step (5), lactate oxidase is immobilized as an enzyme layer on the surface of the working electrode.
In the step (7), polyethylene glycol-polyurethane-Nafion blend liquid is coated on the surface of the working electrode, and the mixture is dried to form a film which is used as a mass transportation limiting layer and an anti-interference coating.
In the step (8), polylactic acid is coated on the surface of the working electrode as a biocompatible coating.
The electrochemical biosensor electrode prepared by the embodiment can be used for lactic acid detection in human blood/body fluid.
Example 3
The difference from example 1 is that:
in the step (1), a screen printing carbon paste electrode is carried out on the surface of a polydimethylsiloxane substrate, and 1% -20% of carbon nanotubes containing active groups such as amino groups, carboxyl groups, hydroxyl groups, succinimide groups and the like are doped.
In step (4), glucose oxidase is pre-blended with an osmium complex, and the osmium complex is supported on the surface of the glucose oxidase.
In the step (5), glucose oxidase loaded with osmium complex is coupled to the surface of the working electrode as an electron transfer mediator-enzyme layer.
In the step (7), the polyurethane-polyurea segmented copolymer is coated on the surface of the working electrode to serve as a mass transportation limiting layer and an anti-interference layer.
In the step (8), a polyvinyl pyridine-styrene copolymer is coated on the surface of the working electrode as a biocompatible coating.
Example 4
The difference from example 1 is that:
in the step (3), the ferrocene solution is infiltrated on the surface of the working electrode, and the ferrocene electron transfer mediator is formed by drying.
In the step (5), lactate oxidase is immobilized as an enzyme layer on the surface of the working electrode.
In the step (7), polyethylene glycol-polyurethane-Nafion blend liquid is coated on the surface of the working electrode, and the mixture is dried to form a film which is used as a mass transportation limiting layer and an anti-interference coating.
In step (8), a biocompatible coating is not required.
The electrochemical biosensor electrode prepared by the embodiment can be used for detecting lactic acid components in a liquid phase system in vitro.
The foregoing is a further detailed description of the invention in connection with the preferred embodiments, and it is not intended that the invention be limited to the specific embodiments described. For those skilled in the art, the architecture of the invention can be flexible and changeable without departing from the concept of the invention, and serial products can be derived. But a few simple derivatives or substitutions should be construed as falling within the scope of the invention as defined by the appended claims.
Claims (10)
1. A method of making an electrochemical biosensor electrode suitable for analyte detection comprising the steps of:
(1) Forming an electrode layer on the surface of a substrate: forming electrode material on the surface of the substrate to form a patterned electrode system, conductive lines and contacts; the electrode system comprises at least one counter electrode, one working electrode and one reference electrode; each electrode is connected with one contact, and at least one conductive circuit is arranged between the electrode and the corresponding contact; the region formed by the whole electrodes is a detection region; the area formed by the whole contacts is a contact area, namely an area electrically connected with external electrical equipment;
(2) Coating Ag/AgCl slurry on the surface of the reference electrode, and drying to form an Ag/AgCl reference electrode;
(3) Modifying an electron transfer mediator or a catalyst on the surface of the working electrode;
(4) Forming an enzyme layer on the surface of the working electrode;
(5) Forming a mass transport limiting layer on the surface of the working electrode:
(6) Forming an anti-interference layer on the surface of the working electrode;
(7) Forming a biocompatible coating on a sensor electrode end of the working electrode;
(8) Immersing the whole modified electrode into 0.01M phosphate buffer solution with pH of 7.4 for 4-48h, so that each component and the coating are fully combined, the stability of the electrode is enhanced, and the prepared electrochemical biosensor electrode is obtained.
2. The method of making an electrochemical biosensor electrode suitable for analyte detection according to claim 1, wherein the substrate can be a flexible or rigid substrate; the flexible substrate is selected from polyimide, polyester, polyether, polydimethylsiloxane, polyvinylpyrrolidone, polyolefin, polytetrafluoroethylene or any copolymer thereof, or flexible glass sheet, flexible metal sheet, inorganic compound oxide film and the like; the rigid substrate is selected from silicon dioxide, metal oxide, hard plastic, ceramic, polymethyl methacrylate, resin or any copolymer thereof;
the electrode material is selected from one of a carbon-based material, a metal material, an inorganic compound material and an organic biochemical material, and the method for forming the electrode coating is screen printing, spraying, coating, infiltration drying, sputtering or electron beam evaporation;
the electrode systems are coplanar, different-surface and different-body.
3. The method of making an electrochemical biosensor electrode suitable for analyte detection according to claim 1, wherein the electron transfer mediator is selected from complexes of the transition metal elements osmium, ruthenium, iron, cobalt, vanadium, or ferricyanide, ferrocenyl derivatives; the catalyst is selected from platinum, silver, gold, lead, nickel, cobalt, titanium, iridium and ruthenium metal nano materials; the process for forming the electron transfer mediator/catalyst is electroplating, electroless plating, sputtering, immersion drying or laser ablation.
4. The method for preparing an electrochemical biosensor electrode for analyte detection according to claim 1, wherein the enzyme layer is formed on the surface of the working electrode by physical adsorption, crosslinking, layer-by-layer assembly, wherein the crosslinking agent is selected from glutaraldehyde, silane coupling agents, succinimide substances, or carbodiimides.
5. The method for preparing an electrochemical biosensor electrode for analyte detection according to claim 1, wherein the material forming the mass transport limiting layer on the surface of the working electrode is selected from the group consisting of polyether, polyurea, polyurethane, polyvinylpyridine, polyvinylimidazole, polyvinylpyrrolidone, styrene-based polymer, polyethylene glycol, polytetrafluoroethylene, polyvinylchloride, polymethyl methacrylate, nafion polymer, chitosan, sodium alginate, agar, and any copolymer thereof; the method for forming the mass transport limiting layer on the surface of the working electrode is spraying, coating or soaking and drying.
6. The method for preparing an electrochemical biosensor electrode for analyte detection according to claim 1, wherein the material forming the anti-interference layer on the surface of the working electrode is selected from the group consisting of polyether, polyurea, polyurethane, polyvinylpyridine, polyvinylimidazole, polyvinylpyrrolidone, styryl polymer, polyethylene glycol, polytetrafluoroethylene, polyvinylchloride, polymethyl methacrylate, nafion polymer and any copolymer thereof; the method for forming the anti-interference layer on the surface of the working electrode is spraying, coating or soaking and drying.
7. The method for preparing an electrochemical biosensor electrode for analyte detection according to claim 1, wherein the material forming the biocompatible coating on the surface of the working electrode is selected from the group consisting of polylactic acid, polyurethane, polyurea, polyether, polyolefin, polyethylene glycol, polyvinyl alcohol, polyvinylpyrrolidone, nafion polymer, chitosan, sodium alginate, agar, and any copolymer thereof.
8. The method of preparing an electrochemical biosensor electrode for analyte detection according to claim 1, wherein after step (2), the electron transfer mediator/catalyst and enzyme are pre-attached and co-incubated on the surface of the working electrode, followed by step (5).
9. The method of preparing an electrochemical biosensor electrode suitable for analyte detection according to claim 1, wherein after step (3), the enzyme and mass transport limiting material are pre-mixed and co-incubated on the working electrode surface; then, step (6) is carried out.
10. The method of preparing an electrochemical biosensor electrode suitable for analyte detection according to claim 1, wherein the mass transport limiting material, the anti-interference material and the biocompatible material in steps (5) (6) (7) are pre-mixed and co-incubated on the same layer of the working electrode surface.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311375842.0A CN117647571A (en) | 2023-10-20 | 2023-10-20 | Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311375842.0A CN117647571A (en) | 2023-10-20 | 2023-10-20 | Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117647571A true CN117647571A (en) | 2024-03-05 |
Family
ID=90042298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311375842.0A Pending CN117647571A (en) | 2023-10-20 | 2023-10-20 | Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117647571A (en) |
-
2023
- 2023-10-20 CN CN202311375842.0A patent/CN117647571A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU675670B2 (en) | Techniques to improve the performance of electrochemical sensors | |
US11266332B2 (en) | Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating | |
Jaffari et al. | Recent advances in amperometric glucose biosensors for in vivo monitoring | |
Heller et al. | Electrochemical glucose sensors and their applications in diabetes management | |
Abel et al. | Biosensors for in vivo glucose measurement: can we cross the experimental stage | |
EP1841363B1 (en) | Catheter-free implantable needle biosensor | |
Heller et al. | Electrochemistry in diabetes management | |
Pantano et al. | Enzyme‐modified microelectrodes for in vivo neurochemical measurements | |
Jia et al. | Elimination of electrochemical interferences in glucose biosensors | |
CA2888644C (en) | Microarray electrodes useful with analyte sensors and methods for making and using them | |
CN101530327A (en) | Needle amperometric determination type glucose sensor for subcutaneous tissue real-time monitoring and manufacturing method thereof | |
TW201010670A (en) | Electrode system for measuring an analyte concentration under in-vivo conditions | |
Jaffari et al. | Novel hexacyanoferrate (III)-modified carbon electrodes: application in miniaturized biosensors with potential for in vivo glucose sensing | |
Wang et al. | One-step electropolymeric co-immobilization of glucose oxidase and heparin for amperometric biosensing of glucose | |
CN117647571A (en) | Electrochemical biosensor electrode suitable for analyte detection and preparation method thereof | |
Turner | Electrochemical sensors for continuous monitoring during surgery and intensive care | |
US20240065585A1 (en) | Sensors for 3-hydroxybutyrate detection | |
EP3928697A1 (en) | Analyte sensor and a method for producing an analyte sensor | |
Pickup et al. | EUROPEAN ACHIEVEMENTS IN SENSOR RESEARCH DEDICATED TO IN VIVO MONITORING-(a) Glucose | |
He et al. | Helical Microfilament‐Electrode‐Based Semi‐Implantable Biosensors for In Vivo Electrochemical Detection | |
WO2024030031A1 (en) | Ketone sensor | |
CN116649970A (en) | Sensor for monitoring lactic acid and preparation method thereof | |
CN117942073A (en) | Enzyme mediator functionalized polymers for use with analyte sensors | |
CN115644866A (en) | Application of SEBS (styrene-ethylene-butylene-styrene) as implantable bioelectrode substrate and implantable bioelectrode | |
WO2022093574A1 (en) | Glucose biosensors comprising direct electron transfer enzymes and methods of making and using them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |